A record of what Mark Mobius said publicly, with the source. Not advice.
Pending — not yet graded
“Bullish on the pharmaceuticals sector, anticipating increased demand from US pharmaceutical companies seeking lower-priced drugs, which India can supply. This makes the sector very interesting going forward.”
Nifty PharmaBullishCalled 12 May 2025
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.
Read the original articleSee Mark Mobius’s full track record